Compare AEON & HERZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AEON | HERZ |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 5 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.8M | 23.7M |
| IPO Year | N/A | N/A |
| Metric | AEON | HERZ |
|---|---|---|
| Price | $1.14 | $15.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.20 | N/A |
| AVG Volume (30 Days) | ★ 66.3K | 10.8K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.38 | $1.62 |
| 52 Week High | $1.45 | $19.30 |
| Indicator | AEON | HERZ |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 59.63 |
| Support Level | $1.01 | $13.85 |
| Resistance Level | $1.12 | $17.20 |
| Average True Range (ATR) | 0.10 | 0.71 |
| MACD | -0.00 | -0.47 |
| Stochastic Oscillator | 34.77 | 57.01 |
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
Herzfeld Credit Income Fund Inc is a non-diversified, closed-end management investment company. Its primary investment objective is to maximize risk-adjusted total returns, and its secondary investment objective is to generate high current income.